Cargando…
Successful Treatment of COVID-19 Patient on ECMO Using Mesenchymal Stromal Cells (MSC)-Derived Exosomes: A Case Report
INTRODUCTION: The use of mesenchymal stromal cells (MSC) was recently proposed as a promising intervention for COVID-19 related respiratory failure (RF). Prior studies have suggested that its larger size might lead to entrapment in extracorporeal membrane oxygenation (ECMO), affect circuit function,...
Autores principales: | Patel, S., Aleman, R., Henninger, M., Montero, O., Perez, J. Balzan, Sheffield, C., Navia, J., Brozzi, N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071362/ http://dx.doi.org/10.1016/j.healun.2022.01.777 |
Ejemplares similares
-
Impact of Sars COV2 infection on acute myocarditis: Observational study of patients admitted from 2019 to 2021
por: Pasqualini, M.E., et al.
Publicado: (2023) -
Ambulation in Veno-Arterial-Venous (VAV) Cannulation for ECMO Support in COVID-19 Related ARDS with Right Ventricular Failure
por: Patel, S., et al.
Publicado: (2022) -
Mesenchymal stromal/stem cell (MSC)-derived exosomes in clinical trials
por: Lotfy, Ahmed, et al.
Publicado: (2023) -
Shifting surgical archetypes of ICG fluorescent‐angiography for bowel perfusion assessment in cardiogenic shock under ECMO support
por: Aleman, Rene, et al.
Publicado: (2022) -
The pandemic effect: The outlook of lung transplantation
por: Aleman, Rene, et al.
Publicado: (2023)